CAFC
21-2121
Mylan Pharmaceuticals Inc v. Merck Sharp & Dohme Corp
General
Filed07/09/21
Appeal FromPTAB
Originating CaseIPR2020-00040
Decision09/29/22
Appeal OutcomeAppellee
PACER21-2121
Judges
Judge | Cases | PO Affirm Rate | Ch Affirm Rate |
|---|---|---|---|
2000+ | 80% | 30% | |
1000+ | 77% | 29% | |
900+ | 75% | 29% |
Appellant
Party
Attorney
Appellee
Party
Attorney